These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 10576649
1. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. Traunecker HC, Stevens MC, Kerr DJ, Ferry DR. Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649 [Abstract] [Full Text] [Related]
2. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
3. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Gosland MP, Gillespie MN, Tsuboi CP, Tofiq S, Olson JW, Crooks PA, Aziz SM. Cancer Chemother Pharmacol; 1996 Nov 21; 37(6):593-600. PubMed ID: 8612315 [Abstract] [Full Text] [Related]
4. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker WG, Bauer D, Etiz BB, Newman RA, Sikic BI. Cancer Res; 1986 May 21; 46(5):2369-73. PubMed ID: 3754487 [Abstract] [Full Text] [Related]
5. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T. Cancer Res; 1993 Oct 01; 53(19):4595-602. PubMed ID: 8402633 [Abstract] [Full Text] [Related]
6. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5. Choi JS, Kang NS, Min YK, Kim SH. Phytother Res; 2010 Jul 01; 24(7):1042-6. PubMed ID: 19960428 [Abstract] [Full Text] [Related]
7. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells. Wang E, Lee MD, Dunn KW. J Cell Physiol; 2000 Aug 01; 184(2):263-74. PubMed ID: 10867652 [Abstract] [Full Text] [Related]
8. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines. Roomi MW, Kalinovsky T, Roomi NW, Rath M, Niedzwiecki A. Oncol Rep; 2012 Jan 01; 27(1):17-27. PubMed ID: 21947138 [Abstract] [Full Text] [Related]
9. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F. J Biol Regul Homeost Agents; 2010 Jan 01; 24(2):197-205. PubMed ID: 20487633 [Abstract] [Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs. Angelini A, Iezzi M, Di Febbo C, Di Ilio C, Cuccurullo F, Porreca E. Oncol Rep; 2008 Oct 01; 20(4):731-5. PubMed ID: 18813811 [Abstract] [Full Text] [Related]
11. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening. Wesolowska O, Paprocka M, Kozlak J, Motohashi N, Dus D, Michalak K. Anticancer Res; 2005 Oct 01; 25(1A):383-9. PubMed ID: 15816562 [Abstract] [Full Text] [Related]
12. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Gosland MP, Lum BL, Sikic BI. Cancer Res; 1989 Dec 15; 49(24 Pt 1):6901-5. PubMed ID: 2582432 [Abstract] [Full Text] [Related]
13. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P. Br J Cancer; 2000 Aug 15; 83(3):366-74. PubMed ID: 10917553 [Abstract] [Full Text] [Related]
14. The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. Myer MS, Joone G, Chasen MR, van Rensburg CE. Oncol Rep; 1999 Aug 15; 6(1):217-8. PubMed ID: 9864431 [Abstract] [Full Text] [Related]
15. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Gosland M, Tsuboi C, Hoffman T, Goodin S, Vore M. Cancer Res; 1993 Nov 15; 53(22):5382-5. PubMed ID: 8106146 [Abstract] [Full Text] [Related]
16. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD. Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444 [Abstract] [Full Text] [Related]
17. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. Angelini A, Centurione L, Sancilio S, Castellani ML, Conti P, Di Ilio C, Porreca E, Cuccurullo F, Di Pietro R. J Biol Regul Homeost Agents; 2011 Jun 01; 25(2):203-11. PubMed ID: 21880209 [Abstract] [Full Text] [Related]
18. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Hua J, Mutch DG, Herzog TJ. Gynecol Oncol; 2005 Jul 01; 98(1):31-8. PubMed ID: 15921732 [Abstract] [Full Text] [Related]
19. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY. Angelini A, Ciofani G, Conti P. J Biol Regul Homeost Agents; 2015 Jul 01; 29(2):357-65. PubMed ID: 26122223 [Abstract] [Full Text] [Related]
20. Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells. Chu ES, Yow CM, Shi M, Ho RJ. Toxicol Lett; 2008 Sep 01; 181(1):7-12. PubMed ID: 18625294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]